Fidelity Investments
WHWK

Fidelity Investments’s Whitehawk Therapeutics WHWK Stock Holding History

Fidelity Investments’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,600
Closed -$5.36K – 5868
2024
Q3 		$5.36K Sell
2,600
-14,344
-85% -$23.2K ﹤0.01% 4616
2024
Q2 		$24.7K Buy
16,944
+12,935
+323% +$24K ﹤0.01% 3969
2024
Q1 		$9.38K Buy
4,009
+1,467
+58% +$2.83K ﹤0.01% 4301
2023
Q4 		$5.13K Buy
2,542
+323
+15% +$1.35K ﹤0.01% 4443
2023
Q3 		$10.7K Buy
2,219
+1,416
+176% +$8.23K ﹤0.01% 4090
2023
Q2 		$5.49K Sell
803
-3,321
-81% -$25.8K ﹤0.01% 4338
2023
Q1 		$29.9K Buy
4,124
+3,852
+1,416% +$41.2K ﹤0.01% 3661
2022
Q4 		$3.49K Sell
272
-2,224
-89% -$29K ﹤0.01% 4364
2022
Q3 		$35K Buy
2,496
+2,437
+4,131% +$32K ﹤0.01% 3618
2022
Q2 		$1K Buy
+59
New +$876 ﹤0.01% 4825
2018
Q4 		– Sell
-37,700
Closed -$1.75M – 4254
2018
Q3 		$1.75M Sell
37,700
-20,907
-36% -$1.17M ﹤0.01% 2393
2018
Q2 		$3.65M Buy
+58,607
New +$3.54M ﹤0.01% 2223

Other funds holding WHWK

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $122M AUM 67.29% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments's WHWK Position: Q4 2024 in Review

Fidelity Investments sold out of Whitehawk Therapeutics (WHWK) in Q4 2024, closing a stake of 2,600 shares — an estimated $5.36K sold.

Fidelity Investments first reported a position in WHWK in Q2 2018 and held it in 12 quarters. The position peaked at $3.65M in Q2 2018. 53 funds tracked by Wall St. Rank hold WHWK as of Q4 2024.

  • Fidelity Investments reported no remaining Whitehawk Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Fidelity Investments sold 2,600 Whitehawk Therapeutics shares in Q4 2024, an estimated $5.36K.
  • Fidelity Investments first reported a position in Whitehawk Therapeutics in Q2 2018 and held it in 12 quarters.
  • Fidelity Investments's Whitehawk Therapeutics position peaked at $3.65M in Q2 2018.
  • 53 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q4 2024.

Based on Fidelity Investments's 13F filing for Q4 2024, filed 13 Feb 2025.